- Home
- AIMD vs AQMS Comparison
AIMD vs AQMS Comparison
Compare AIMD & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- AQMS
- Stock Information
- Founded
- AIMD 1984
- AQMS 2014
- Country
- AIMD United States
- AQMS United States
- Employees
- AIMD N/A
- AQMS N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- AIMD Health Care
- AQMS Industrials
- Exchange
- AIMD Nasdaq
- AQMS Nasdaq
- Market Cap
- AIMD 8.2M
- AQMS 7.7M
- IPO Year
- AIMD N/A
- AQMS 2015
- Fundamental
- Price
- AIMD $0.51
- AQMS $0.52
- Analyst Decision
- AIMD
- AQMS Strong Buy
- Analyst Count
- AIMD 0
- AQMS 3
- Target Price
- AIMD N/A
- AQMS $21.00
- AVG Volume (30 Days)
- AIMD 259.6K
- AQMS 497.3K
- Earning Date
- AIMD 08-04-2025
- AQMS 08-04-2025
- Dividend Yield
- AIMD N/A
- AQMS N/A
- EPS Growth
- AIMD N/A
- AQMS N/A
- EPS
- AIMD N/A
- AQMS N/A
- Revenue
- AIMD $106,207.00
- AQMS N/A
- Revenue This Year
- AIMD N/A
- AQMS N/A
- Revenue Next Year
- AIMD N/A
- AQMS $550.00
- P/E Ratio
- AIMD N/A
- AQMS N/A
- Revenue Growth
- AIMD 13.38
- AQMS N/A
- 52 Week Low
- AIMD $0.40
- AQMS $0.51
- 52 Week High
- AIMD $1.07
- AQMS $7.92
- Technical
- Relative Strength Index (RSI)
- AIMD 38.36
- AQMS 25.92
- Support Level
- AIMD $0.49
- AQMS $0.53
- Resistance Level
- AIMD $0.52
- AQMS $0.83
- Average True Range (ATR)
- AIMD 0.05
- AQMS 0.11
- MACD
- AIMD -0.01
- AQMS -0.01
- Stochastic Oscillator
- AIMD 12.55
- AQMS 1.28
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.